Aspen Pharmacare Ltd. To Buy Sigma Pharmaceuticals Drugs Arm For $804 Million (A$900 Million)

Published: Aug 16, 2010

MELBOURNE (Reuters) - South Africa's Aspen Pharmacare (APNJ.J), in a recrafted deal, has agreed to buy the drugmaking arm of Australia's Sigma Pharmaceuticals (SIP.AX) for $804 million cash, giving it control of about a quarter of Australia's generic drugs market.

Back to news